Dissection of the enzymatic and immunologic functions of macrophage migration inhibitory factor - Full immunologic activity of N-terminally truncated mutants

被引:42
作者
Kleemann, R
Rorsman, H
Rosengren, E
Mischke, R
Mai, NT
Bernhagen, J
机构
[1] Univ Stuttgart, Inst Interfacial Engn, Biochem Lab, D-70569 Stuttgart, Germany
[2] Univ Lund Hosp, Dept Dermatol, S-22185 Lund, Sweden
[3] Univ Lund Hosp, Dept Pharmacol, S-22185 Lund, Sweden
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2000年 / 267卷 / 24期
关键词
cytokine; macrophage migration inhibitory factor (MIF); N-terminal mutation; oxidoreductase; tautomerase;
D O I
10.1046/j.1432-1327.2000.01823.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophage migration inhibitory factor (MIF) is a cytokine with broad regulatory functions in innate immunity. MIF belongs to the few cytokines displaying catalytic activities, i.e. MIF has a Pro2-dependent tautomerase and a Cys-Ala-Leu-Cys (CALC) cysteine-based thiol-protein oxidoreductase activity. Previous studies have addressed the roles of the catalytic site residues and the C-terminus. The two activities have not been directly compared. Here we report on the N-terminal mutational analysis and minimization of MIF and on a dissection of the two catalytic activities by comparing mutants P2AMIF, Delta 4MIF, Delta 5MIF Delta 6MIF, Delta 7MIF Delta 8MIF, and Delta 10MIF with the cysteine mutants of MIF. As N-terminal deletion was predicted to interfere with protein structure due to disruption of the central beta sheet, it was surprising that deletion of up to six N-terminal residues resulted in normally expressed proteins with wild-type conformation. Strikingly, such mutants exhibited full MIF-specific immunologic activity. While mutation of Pro2 eliminated tautomerase activity, the CALC cysteine residues had no influence on this activity. However, mutant C81SMIF, which otherwise has full biologic activity, only had 32% tautomerase activity. Deletion of four N-terminal residues did not interfere with insulin reduction by MIF. By contrast, reduction of 2-hydroxyethyldisulfide (HED) was markedly affected by N-terminal manipulation, with P2AMIF and Delta 2MIF exhibiting 40% activity, and Delta 4MIF completely failing to reduce HED. This study constitutes the first comparison of the two catalytic activities of MIF and should assist in understanding the molecular links between the catalytic and immunologic activities of this cytokine and in providing guidelines for N-terminal protein minimization.
引用
收藏
页码:7183 / 7192
页数:10
相关论文
共 73 条
[1]   An essential regulatory role for macrophage migration inhibitory factor in T-cell activation [J].
Bacher, M ;
Metz, CN ;
Calandra, T ;
Mayer, K ;
Chesney, J ;
Lohoff, M ;
Gemsa, D ;
Donnelly, T ;
Bucala, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7849-7854
[2]   MIF expression in the rat brain: Implications for neuronal function [J].
Bacher, M ;
Meinhardt, A ;
Lan, HY ;
Dhabhar, FS ;
Mu, W ;
Metz, CN ;
Chesney, JA ;
Gemsa, D ;
Donnelly, T ;
Atkins, RC ;
Bucala, R .
MOLECULAR MEDICINE, 1998, 4 (04) :217-230
[3]   Neutralizing antiviral B cell responses [J].
Bachmann, MF ;
Zinkernagel, RM .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :235-270
[4]   Biochemical and nutational investigations of the enzymatic activity of macrophage migration inhibitory factor [J].
Bendrat, K ;
AlAbed, Y ;
Callaway, DJE ;
Peng, T ;
Calandra, T ;
Metz, CN ;
Bucala, R .
BIOCHEMISTRY, 1997, 36 (49) :15356-15362
[5]   MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].
BERNHAGEN, J ;
CALANDRA, T ;
MITCHELL, RA ;
MARTIN, SB ;
TRACEY, KJ ;
VOELTER, W ;
MANOGUE, KR ;
CERAMI, A ;
BUCALA, R .
NATURE, 1993, 365 (6448) :756-759
[6]   PURIFICATION, BIOACTIVITY, AND SECONDARY STRUCTURE-ANALYSIS OF MOUSE AND HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) [J].
BERNHAGEN, J ;
MITCHELL, RA ;
CALANDRA, T ;
VOELTER, W ;
CERAMI, A ;
BUCALA, R .
BIOCHEMISTRY, 1994, 33 (47) :14144-14155
[7]   Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features [J].
Bernhagen, J ;
Calandra, T ;
Bucala, R .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (3-4) :151-161
[8]   An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction [J].
Bernhagen, J ;
Bacher, M ;
Calandra, T ;
Metz, CN ;
Doty, SB ;
Donnelly, T ;
Bucala, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :277-282
[9]   Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells [J].
Bertini, R ;
Howard, OMZ ;
Dong, HF ;
Oppenheim, JJ ;
Bizzarri, C ;
Sergi, R ;
Caselli, G ;
Pagliei, S ;
Romines, B ;
Wilshire, JA ;
Mengozzi, M ;
Nakamura, H ;
Yodoi, J ;
Pekkari, K ;
Gurunath, R ;
Holmgren, A ;
Herzenberg, LA ;
Herzenberg, LA ;
Ghezzi, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (11) :1783-1789
[10]   MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY [J].
BLOOM, BR ;
BENNETT, B .
SCIENCE, 1966, 153 (3731) :80-&